Skip to main content

Low levels of CC16 in nasal fluid of children with birch pollen-induced rhinitis

The full text article is not available.


Clara cell protein 16 (CC16; secretoglobin 1A1) is an anti-inflammatory protein mainly expressed in the epithelial cells in the airways. Objective: 

To compare the levels of CC16 in nasal lavage (NAL) from children with intermittent allergic rhinitis and healthy controls and to study the effect of a local steroid. Methods: 

Thirty schoolchildren with birch pollen allergy and 30 healthy controls from the same schools were included in the study. The NAL fluid was collected before the season, during the birch pollen season and, for the patients, after 1 week of treatment with a local steroid. Symptom scores were obtained on every occasion. CC16 and eosinophil cationic protein (ECP) were analyzed with enzyme-linked immunosorbent assay. Results: 

The nasal fluid levels of CC16 were significantly lower in patients than in controls, before and during pollen season. Before the season, the median CC16 concentrations were 9.1 (range 1.1–117) g/l in patients and 25.7 (6.1–110.2) g/l in controls. During the season, the median CC16 concentrations in nasal fluid were 12.9 (2.3–89.7) g/l in the allergic children and 22.0 (9.5–90.1) g/l in the healthy controls (P = 0.0005). Symptom scores, nasal fluid eosinophils and ECP were higher in patients during the season. Treatment with a local steroid did not change the CC16 levels. Conclusions: 

Nasal fluid CC16 levels were lower in children with birch pollen-induced allergic rhinitis than in healthy controls both before and during the pollen season. We speculate that reduction in anti-inflammatory activity by CC16 may contribute to the pathogenesis of allergic rhinitis.
No References
No Citations
No Supplementary Data
No Article Media
No Metrics

Keywords: CC16; Clara cell; allergic rhinitis; children; secretoglobin 1a1

Document Type: Research Article

Affiliations: 1: Department of Pediatrics, Göteborg University, Queen Silvia Children's Hospital 2: Department of Respiratory Medicine and Allergology, Göteborg University, Sahlgrenska Hospital, Göteborg, Sweden

Publication date: 2005-05-01

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more